Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
alpha-synuclein
amantadine
anosmia
aphasia
aphasia, progressive, primary
asymptomatic
atypical
autonomic dysfunction
Babinski sign
basal ganglia, infarction
behavioral disorder
biologic markers
bladder dysfunction
bradykinesia
brain transplantation
carotid artery disease
carotid artery disease, asymptomatic
carotid artery disease, medical management
carotid artery stenosis
CAT scan, emission
CAT scan, emission, abnormal
cerebral infarction
cerebral infarction, subcortical
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular disease
cerebrovascular disease, surgical treatment of
chromosome 17
chromosome 6
complications
constipation
controversies in neurology
degenerative diseases of CNS
delusion
dementia
dementia, age at onset
dementia, familial
dementia, frontal lobe type
dementia, frontotemporal
dementia, presenile
dementia, rapidly progressive
deprenyl
depression
diagnostic criteria
diet
differential diagnosis
digital health, wearable technology
disability rating scale, neurological
disability, neurological
dopamine agonist
dopamine receptor
dyskinesia
dyskinesia, drug induced
dystonia
endarterectomy, carotid
enzyme inhibition
epidemiology of neurology
familial
farmer
fetal tissue
fetus
fluency
frontotemporal dementia, behavioral variant
gait disorder
gene
gene mutation
genetic neurologic disorders
genetic testing
gray matter
hallucination
head injury
hemiparesis
heralding manifestation
herbicide
highly active antiretroviral therapy
hormone replacement
human genome
human immunodeficiency virus type 1
hyperosmia
hyperreflexia
hypersomnia
hyposmia
hypotension, systemic
imbalance
inflexibility, mental
insecticides
intellectual deficit
L-dopa
L-dopa, delayed treatment in Parkinsonism
L-dopa, drug interactions with and side effects of
Lewy body
Lewy body disease, diffuse
life expectancy
lobar atrophy
misdiagnosis
monoamine oxidase inhibitors
mortality
motor neuron disease
movement disorder
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, diffusion tensor
MRI, functional
neuroleptic, atypical
neurologic complications of, surgery
neurologic disease
neurologic disease, diagnoses of
neurologic symptoms
neuropathology
neuropathology, brain
neuroprotective agents
neurotoxic
neurotoxin
old age, neurology of
orthostatic hypotension
pain, increased response
pallidotomy
Parkinson disease
Parkinson disease, acute onset
Parkinson disease, arteriosclerotic
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, duration
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, familial
Parkinson disease, fluctuations in
Parkinson disease, freezing phenomena in
Parkinson disease, hemiparesis in
Parkinson disease, heterogeneity of
Parkinson disease, late onset
Parkinson disease, L-dopa nonresponsive
Parkinson disease, misdiagnosis
Parkinson disease, mode of onset
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, presymptomatic detection
Parkinson disease, prognosis of
Parkinson disease, progression
Parkinson disease, rapid progression
Parkinson disease, surgical treatment of
Parkinson disease, transient
Parkinson disease, treatment of
Parkinson disease, unilateral
Parkinson disease, wearing off
Parkinson disease, young onset
Parkinsonism syndrome
Parkinsonism-dementia complex
pergolide
personality change
polymerase chain reaction
pramipexole
preclinical
premarin
prevention of neurologic disorders
PRKN gene
prognosis
progressive neurologic disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
quetiapine
radiotracer imaging
rasagiline
release phenomena
REM sleep
REM sleep behavior disorder
revascularization, surgical
review article
risk factors
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
Smell Identification Test
solvent
speech disorder
stereotyped behavior
stimulation, deep brain
substantia nigra
syncope
synucleinopathy
tonic foot response
trauma
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
trichloroethylene
turning slowly
ultraprocessed foods
walking, difficulty with
watershed infarcts
weight loss
word-finding difficulty
Showing articles 600 to 650 of 2766 << Previous Next >>

Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
Stroke 40:3646-3678, Latchaw,R.,et al, 2009

Deep Brain Stimulation for Tourette Syndrome
Neurol 73:e87-e90, Black,K., 2009

Thalmic Deep Brain Stimulation for Treatment-Refractory Tourette Syndrome
Neurol 73:1375-1380,e87, Porta,M.,et al, 2009

Real-Life Impact of Early Interferon� Therapy in Relapsing Multiple Sclerosis
Ann Neurol 66:513-520, Trojano,M.,et al, 2009

Family History of Melanoma and Parkinson Disease Risk
Neurol 73:1286-1291, Gao,X.,et al, 2009

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinsons Disease
NEJM 361:1268-1278, 1304, Olanow,C.,et al, 2009

Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-Up of 70 Patients
Arch Neurol 66:841-846, Lebrun,C.,et al, 2009

Long-Term Effects of Pallidal Deep Brain Stimulation in Tradive Dystonia
Neurol 73:53-58, Gruber,D.,et al, 2009

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
Neurol 72:2076-2082,2064, Makhani,N.,et al, 2009

Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009

Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
Arch Neurol 66:1345-1352, Moraal,B.,et al, 2009

Effect of Glatiramer Acetate on Conversion to Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndrome (PreCISe study): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 374:1503-1511, 1475, Martinelli,G.,et al, 2009

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Levodopa for the Treatment of Parkinsons Disease
NEJM 359:2468-2476, LeWitt,P.A., 2008

Tau Forms in CSF as a Reliable Biomarker for Progressive Supranuclear Palsy
Neurol 71:1796-1803, Borroni,B.,et al, 2008

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Internal Pallidal and Thalamic Stimulation in Patients With Tourette Syndrome
Arch Neurol 65:952-957, Welter,M.-L.,et al., 2008

Fourteen-Year Final Report of the Randomized PDRG-UK Trial Comparing Three Treatments in PD
Neurol 71:474-480.470, Katzenschlager,R.,et al., 2008

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

Subthalamic Nucleus Stimulation in Severe Obsessive-Compulsive Disorder
NEJM 359:2121-2134, Mallet,L.,et al, 2008

Rhinorrhea and Olfaction in Parkinson Disease
Neurol 70:487-489, Friedman, J.H.,et al, 2008

Fragile X-Associated Tremor/Ataxia Syndrome: An Aging Face of the Fragile X Gene
Arch Neurol 65:19-25, Amiri,K.,et al, 2008

Increased Risk of Parkinsonism in Women Who Underwent Oophorectomy Before Menopause
Neurol 70:200-209, Rocca,W.A.,et al, 2008

Functional Imaging of the Cerebral Olfactory System in Patients with Parkinsons Disease
JNNP 79:19-24, Westermann,B.,et al, 2008

Foreign Accent Syndrome as the Initial Sign of Primary Progressive Aphasia
JNNP 79:79-81, Luzzi,S.,et al, 2008

a-Synuclein Gene Duplication Is Present in Sporadic Parkinson Disease
Neurol 70:43-49,7, Ahn,T.-B.,et al, 2008

A 23-Year-Old Man With Seizures and Visual Deficit
Neurol 70:73-78, Boustany,R.-M.,et al, 2008

Bacterial and Fungal Meningitis in Patients With Cancer
Neurol 70:943-947, Safdieh,J.E.,et al, 2008

Subthalamic Lesion on MR Imaging in a Patient With Nonketotic Hyperglycemia-Induced Hemiballism
AJNR 29:526-527, Kim,H.-J.,et al, 2008

A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008

Restless Arms
Lancet 371:530, Horvath,J.,et al, 2008

Lumbar Spinal Stenosis
NEJM 358:818-825, Katz,J.N. &Harris,M.B., 2008

Unexpected Multiple Sclerosis: Follow-Up of 30 Patients With Magnetic Resonance Imaging and Clinical Conversion Profile
JNNP 79:195-198,112, Lebrun,C.,et al, 2008

Deep Brain Stimulation in 18 Patients With Severe Gilles de la Tourette Syndrome Refractory to Treatment: The Surgery and Stimulation
JNNP 79:136-142,111, Servello,D.,et al, 2008

Stereotactic Radiosurgery for Treatment of Epilepsy
Arch Neurol 65:177-183, Quigg,M. &Barbaro,N.M., 2008

Psychogenic Tremor Occurring After Deep Brain Stimulation Surgery for Essential Tremor
Neurol 70:1498-1499, McKeon,A.,et al, 2008

Statin Use and the Risk of Parkinson Disease
Neurol 70:1418-1422, Wahner,A.D.,et al, 2008

Use of Antihypertensives and the Risk of Parkinson Disease
Neurol 70:1438-1444, Becker,C.,et al, 2008

Functional Imaging in Parkinson Disease
Neurol 70:1478-1488, Nandhagopal,R.,et al, 2008

Diagnosis and Management of Motor Neurone Disease
BMJ 336:658-662, McDermott,C.J. &Shaw,P.J., 2008

Do Oligoclonal Bands Add Information to MRI in First Attacks of Multiple Sclerosis?
Neurol 70:1079-1083,1059, Tintore,M.,et al, 2008

Dementia and Survival in Parkinson Disease: A 12-Year Population Study
Neurol 70:1017-1022, Buter,T.C.,et al, 2008

When to Expect Negative Diffusion-Weighted Images in Stroke and Transient Ischemic Attack
Stroke 39:1898-1900, Sylaja,P.N.,et al, 2008

Invited Article: Changing Concepts in Parkinson Disease: Moving Beyond the Decade of the Brain
Neurol 70:1996-2003, Marras,C. &Lang,A., 2008

Invited Article: Nervous System Pathology in Sporadic Parkinson Disease
Neurol 70:1916-1925, Braak,H. & Del Tredici,K., 2008

Anteroir Cerebral Artery Infarction: Stroke Mechanism and Clinical-Imaging Study in 100 Patients
Neurol 70:2386-2393, Kang,S.Y. &Kim,J.S., 2008

Reversible Parkinsonism and Ataxia Associated With High-Dose Octreotide
Neurol 70:2345-2346, Espay,A.J., 2008

Serum Uric Acid and Clinical Progression in Parkinson Disease: Potential Biomarker for Nigrostriatal Failure
Arch Neurol 65:698-699, Schiess,M. &Oh,I., 2008



Showing articles 600 to 650 of 2766 << Previous Next >>